Trial intelligence / Profile preview

Menactra in toddlers 9 to 18 months

NCT00643916Phase 2Completed

Sponsor
Sanofi
Start
Dec 2004
Primary completion
Mar 2006
Countries
1
01

Overview

Phase 2, open-label trial of meningococcal A conjugate vaccine in meningococcal meningitis and meningococcal infection, sponsored by Sanofi. Started Dec 2004; status: completed.

02

Drugs

meningococcal A conjugate vaccine
03

Conditions

meningococcal meningitismeningococcal infection

Beyond the preview

Go deeper on NCT00643916.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00643916.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call